In migraineurs, intravenous CGRP administration induces migraine-like symptoms; during acute attacks, elevated CGRP blood levels are observed during active migraine episodes, as well as in chronic versus episodic migraineurs [159,160,161,162]. The gene discussed is CALCA; the disease is migraine disorder.